CAI Caris Life Sciences price target raised to $26 from $25 at Evercore ISI
Very bullish setup.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Very bullish setup.
What happened, with direct paths to the underlying reporting
Target raised to $26; current price $16.45; implied upside ~58%.
Target: $26
Posted price: $16.45
Analyst firm: Evercore ISI
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.